Package Leaflet: Information for the Patient
Sivextro 200mg film-coated tablets
tedizolid phosphate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
if they have the same symptoms as you.
Contents of the pack and other information
Sivextro is an antibiotic that contains the active substance tedizolid phosphate. It belongs to a group of medicines called "oxazolidinones".
Sivextro is a tablet for adults, adolescents, and children weighing at least 35 kg for the treatment of skin and soft tissue infections.
Sivextro works by stopping the growth of certain bacteria that can cause serious infections.
Do not take Sivextro:
Warnings and precautions
Your doctor will decide if Sivextro is suitable for treating your infection.
Tell your doctor or nurse before you start taking Sivextro if any of the following apply to you:
Tell your doctor or pharmacist if you are not sure if you are taking any of these medicines.
Diarrhea
Tell your doctor immediately if you get diarrhea during or after your treatment. Do not take any medicine to treat diarrhea without first checking with your doctor.
Resistance to antibiotics
Bacteria may become resistant to treatment with antibiotics over time. This is when antibiotics cannot stop the growth of bacteria or treat your infection. Your doctor will decide if you should be given Sivextro to treat your infection.
Possible side effects
Some side effects have been seen with Sivextro or another member of the class of oxazolidinones when given for a period longer than recommended for Sivextro. Tell your doctor immediately if you get any of the following side effects while taking Sivextro:
Children
Sivextro 200 mg tablets are indicated for adolescents and children weighing at least 35 kg. For adolescents and children weighing less than 35 kg, tedizolid phosphate powder for concentrate for solution for infusion is available.
Other medicines and Sivextro
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. It is especially important to tell your doctor if you are also taking:
Sivextro may interfere with the effects of these medicines. Your doctor will explain more details.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not known if Sivextro passes into breast milk. Ask your doctor before breast-feeding your baby.
Driving and using machines
Do not drive or use machines if you feel dizzy or tired after taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose is one 200 mg tablet once a day for 6 days. The tablets should be swallowed whole and can be taken with or without food or drink.
Consult a doctor if you do not get better, or if you get worse after 6 days.
If you take more Sivextro than you should
Contact your doctor, pharmacist, or the nearest hospital emergency department immediately if you have taken more tablets than you should, and take the medicine with you.
If you forget to take Sivextro
If you forget to take the medicine, take the dose as soon as you remember, at any time up to 8 hours before the next scheduled dose. If it is less than 8 hours before the next dose, wait until the next scheduled dose. Do not take a double dose to make up for a forgotten dose. If you are not sure, ask your pharmacist.
You must take all 6 tablets to complete the treatment, even if you have missed a dose.
If you stop taking Sivextro
If you stop taking Sivextro without your doctor's advice, your symptoms may get worse. Consult your doctor or pharmacist before stopping the medicine.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediatelyif you get diarrhea during or after your treatment.
Other side effects may include:
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or blister after "EXP". The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Sivextro contains
Appearance and packaging
Sivextro is a yellow, oval, film-coated tablet with "TZD" printed on one side and "200" on the other.
It is available in blister packs of 6 x 1 tablet unit doses.
Marketing Authorisation Holder and Manufacturer
Merck Sharp & Dohme B.V.
Waarderweg 39
2031 BN Haarlem
Netherlands
For further information on this medicine, contact the local representative of the Marketing Authorisation Holder:
Belgium MSD Belgium Tel: +32 (0)2 776 62 11 dpoc_belux@msd.com | Lithuania UAB Merck Sharp & Dohme Tel: +370 5 278 02 47 dpoc_lithuania@msd.com |
Luxembourg MSD Belgium Tel: +32 (0)2 776 62 11 dpoc_belux@msd.com | |
Czech Republic Merck Sharp & Dohme, s.r.o. Tel: +420 233 010 111 dpoc_czechslovak@merck.com | Hungary MSD Pharma Hungary Kft. Tel: +36 1 888 53 00 hungary_msd@merck.com |
Denmark MSD Danmark ApS Tel: +45 44 82 40 00 dkmail@msd.com | Malta Merck Sharp & Dohme Cyprus Limited Tel: 8007 44 33 (+356 999 17 58) malta_info@merck.com |
Germany MSD Sharp & Dohme GmbH Tel: +49 (0)89 20 30 03 0 medinfo@msd.de | Netherlands Merck Sharp & Dohme B.V. Tel: 0800 99 99 00 (+31 23 515 31 53) medicalinfo.nl@merck.com |
Estonia Merck Sharp & Dohme OÜ Tel: +372 614 42 00 dpoc.estonia@msd.com | Norway MSD (Norge) AS Tel: +47 32 20 73 00 medinfo.norway@msd.com |
Greece MSD Α.Φ.Ε.Ε. Tel: +30 210 98 97 300 dpoc_greece@merck.com | Austria Merck Sharp & Dohme Ges.m.b.H. Tel: +43 (0)1 26 044 dpoc_austria@merck.com |
Spain Merck Sharp & Dohme de España, S.A. Tel: +34 91 321 06 00 msd_info@msd.com | Poland MSD Polska Sp. z o.o. Tel: +48 22 549 51 00 msdpolska@merck.com |
France MSD France Tel: +33 (0)1 80 46 40 40 | Portugal Merck Sharp & Dohme, Lda Tel: +351 21 446 57 00 inform_pt@merck.com |
Croatia Merck Sharp & Dohme d.o.o. Tel: +385 1 6611 333 croatia_info@merck.com | Romania Merck Sharp & Dohme Romania S.R.L. Tel: +40 21 529 29 00 msdromania@merck.com |
Ireland Merck Sharp & Dohme Ireland (Human Health) Limited Tel: +353 (0)1 299 87 00 medinfo_ireland@msd.com | Slovenia Merck Sharp & Dohme, inovativna zdravila d.o.o. Tel: +386 1 520 42 01 msd.slovenia@merck.com |
Iceland Vistor ehf. Tel: +354 535 70 00 | Slovakia Merck Sharp & Dohme, s.r.o. Tel: +421 2 5828 20 10 dpoc_czechslovak@merck.com |
Italy MSD Italia S.r.l. Tel: 800 23 99 89 (+39 06 3619 11) dpoc.italy@msd.com | Finland MSD Finland Oy Tel: +358 (0)9 804 65 0 info@msd.fi |
Cyprus Merck Sharp & Dohme Cyprus Limited Tel: 800 00 67 3 (+357 22 86 67 00) cyprus_info@merck.com | Sweden Merck Sharp & Dohme (Sweden) AB Tel: +46 77 570 04 88 medicinskinfo@msd.com |
Latvia SIA Merck Sharp & Dohme Latvija Tel: +371 67 025 30 0 dpoc.latvia@msd.com | United Kingdom (Northern Ireland) Merck Sharp & Dohme Ireland (Human Health) Limited Tel: +353 (0)1 299 87 00 medinfoNI@msd.com |
Date of last revision of this leaflet: {MM/YYYY}.
Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.